Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2000-02-04 (26 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: COURBEVOIE (92400), Hauts-de-Seine
PHARMACIE SAINTE MARIE : revenue, balance sheet and financial ratios
PHARMACIE SAINTE MARIE is a French company
founded 26 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in COURBEVOIE (92400),
this company of category PME
shows in 2024 a revenue of 3.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE SAINTE MARIE (SIREN 430240606)
Indicator
2024
2024
2023
2022
2020
2019
2018
2017
2016
Revenue
N/C
3 202 678 €
3 011 251 €
3 058 926 €
N/C
N/C
2 287 548 €
2 289 053 €
2 398 643 €
Net income
78 868 €
263 471 €
211 194 €
287 752 €
9 975 €
57 034 €
26 973 €
17 208 €
66 778 €
EBITDA
N/C
352 133 €
252 861 €
391 241 €
N/C
N/C
51 932 €
47 630 €
98 774 €
Net margin
N/C
8.2%
7.0%
9.4%
N/C
N/C
1.2%
0.8%
2.8%
Revenue and income statement
In 2024, PHARMACIE SAINTE MARIE generates positive net income of 79 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 67 k€ -> 79 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
78 868 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 285%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 23%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
284.584%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
23.095%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE SAINTE MARIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
2024
Debt ratio
1392.165
4074.239
3292.941
1692.522
6340.168
329.159
190.229
115.492
284.584
Financial autonomy
4.647
1.652
2.227
4.15
1.192
17.164
27.331
37.094
23.095
Repayment capacity
14.12
43.068
58.246
None
None
4.297
5.279
3.709
None
Cash flow / Revenue
3.088%
1.038%
0.873%
None%
None%
9.418%
7.028%
8.271%
None%
Sector positioning
Debt ratio
284.582024
2023
2024
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average
In 2024, the debt ratio of PHARMACIE SAINTE MARIE (284.58) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
23.09%2024
2023
2024
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Watch
In 2024, the financial autonomy of PHARMACIE SAINTE MARIE (23.1%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
3.71 years2024
2023
2024
Q1: 0.52 years
Med: 3.18 years
Q3: 7.6 years
Average-8 pts over 2 years
In 2024, the repayment capacity of PHARMACIE SAINTE MARIE (3.71) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 212.48. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
212.478
Liquidity indicators evolution PHARMACIE SAINTE MARIE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
2024
Liquidity ratio
59.254
48.142
70.417
69.253
63.637
154.271
190.438
214.344
212.478
Interest coverage
28.149
50.514
61.382
None
None
0.961
1.455
0.885
None
Sector positioning
Liquidity ratio
212.482024
2023
2024
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Good+9 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE SAINTE MARIE (212.48) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.89x2024
2023
2024
Q1: 0.0x
Med: 2.34x
Q3: 7.73x
Average
In 2024, the interest coverage of PHARMACIE SAINTE MARIE (0.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE SAINTE MARIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
2024
Operating WCR
114 703 €
93 576 €
138 420 €
0 €
0 €
259 733 €
535 099 €
713 268 €
0 €
Inventory turnover (days)
33
33
35
0
0
40
43
43
0
Customer payment term (days)
3
2
3
0
0
4
2
4
0
Supplier payment term (days)
62
63
49
0
0
33
30
31
0
Positioning of PHARMACIE SAINTE MARIE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE SAINTE MARIE is estimated at
1 101 055 €
(range 766 757€ - 1 647 242€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
766k€1101k€1647k€
1 101 055 €Range: 766 757€ - 1 647 242€
NAF 5 année 2024
Valuation method used
Net Income Multiple
78 868 €
×
14.0x
=1 101 056 €
Range: 766 758€ - 1 647 242€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE SAINTE MARIE with other companies in the same sector:
Frequently asked questions about PHARMACIE SAINTE MARIE
What is the revenue of PHARMACIE SAINTE MARIE ?
The revenue of PHARMACIE SAINTE MARIE in 2024 is 3.2 M€.
Is PHARMACIE SAINTE MARIE profitable?
Yes, PHARMACIE SAINTE MARIE generated a net profit of 79 k€ in 2024.
Where is the headquarters of PHARMACIE SAINTE MARIE ?
The headquarters of PHARMACIE SAINTE MARIE is located in COURBEVOIE (92400), in the department Hauts-de-Seine.
Where to find the tax return of PHARMACIE SAINTE MARIE ?
The tax return of PHARMACIE SAINTE MARIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE SAINTE MARIE operate?
PHARMACIE SAINTE MARIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart